Below you find the latest publications on PubMed that discuss the FinnDiane cohort. For a complete overview click here
- Obesity, kidney disease, and coronary artery disease (CAD) are interconnected. Here, the relationship between central obesity and CAD across albuminuria categories in type 1 diabetes was investigated. Data on 4,349 individuals without prior CAD from the Finnish Diabetic Nephropathy Study were analyzed. Central obesity was defined as waist-to-height ratio (WHtR) ≥0.5. Outcomes included acute myocardial […]
- CONCLUSIONS: Enlarged FAZ was associated with poorer working memory performance independently of confounding factors. Otherwise, age largely explained the associations between retinal microvascular structure and cognition in middle-aged individuals with type 1 diabetes without any overt neurological symptoms.
- BACKGROUND: The incidence and risk profiles of ST-elevation myocardial infarction (STEMI) and non-ST-elevation myocardial infarction (NSTEMI) are understudied in type 1 diabetes. We aimed to study the similarities and differences in the incidence and risk profiles of myocardial infarction subtypes in people with type 1 diabetes.
- CONCLUSIONS: Findings highlight the clinical potential of identifying individuals at increased risk of HF, PAD, and all-cause mortality at an early stage among those with T1D without albuminuria by evaluating both eGFRcys and eGFRcr and their discrepancy.
- CONCLUSIONS/INTERPRETATION: The current study detected 11 loci associated with DKD progression, identifying methylation changes predictive of early-stage DKD progression in type 1 diabetes for the first time. Future research is needed to establish prognostic DNA methylation markers for DKD progression.
